Utilization of VADs in children with restrictive and hypertrophic cardiomyopathy: Are we there yet?. (June 2018)

• Record Type: Journal Article
• Authors: Villa, Chet; Broderick, John; Rizwan, Raheel; Lorts, Angela
• Is Part Of: Progress in pediatric cardiology. Volume 49(2018)
• Page Start: 47
• Page End: 49
• Publication Date: 2018-06
• Subjects: Heart transplant -- Ventricular assist device -- Restrictive cardiomyopathy -- Outcomes -- Pediatric; Pediatric cardiology -- Periodicals; Cardiovascular Diseases -- Periodicals; Infant; Child; Cardiologie pédiatrique -- Périodiques; 618.9212005
• DOI: 10.1016/j.ppedcard.2018.03.003
• Languages: English
• ISSNs: 1058-9813

Abstract

Abstract: Pediatric Ventricular assist device (VAD) use in pediatrics has increased dramatically over the last decade. Over a quarter of children are currently supported with a VAD until a suitable organ becomes available. The majority of these patients have dilated cardiomyopathy (DCM), though some have congenital heart disease, restrictive cardiomyopathy (RCM) or hypertrophic cardiomyopathy (HCM). Patients with restrictive cardiomyopathy or hypertrophic cardiomyopathy remain difficult to support due to anatomic limitations and the limited number of devices currently available to children. This review discusses the past experience and potential for increased use of VADs in pediatric patients with RCM and HCM. Highlights: Restrictive cardiomyopathy (RCM) patients are rarely bridged to transplant (BTT) with a ventricular assist device (VAD). Hypertrophic cardiomyopathy (HCM) are rarely BTT with a ventricular assist device (VAD). Patients with RCM and HCM can be BTT with a VAD using novel cannulation strategies and a variety of devices.